Status:
COMPLETED
Behavioral Approaches to Reducing Diabetes Distress and Improving Glycemic Control
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Type 1 Diabetes
Diabetes Distress
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This study is comparing three programs to reduce Diabetes Distress (the worries and concerns that people with diabetes may experience as they struggle to keep blood glucose levels in range) in adults ...
Detailed Description
Diabetes Distress (DD) is the personal, often hidden side of diabetes: it reflects the unique emotional burdens and strains that individuals with diabetes may experience as they struggle to keep blood...
Eligibility Criteria
Inclusion
- Adult patients with type 1 diabetes (confirmed by clinical history and/or anti-glutamic acid decarboxylase\] antibody testing) on intensive insulin treatment;
- Diagnosis of type 1 diabetes for at least 12 months that occurred at or below age 40;
- Have a recent HbA1c of 7.5% or higher;
- Not have started to use any new (to the participant) diabetes device (such as an insulin pump or continuous glucose monitor) in the past 6 months;
- Internet access through a computer or smart phone;
- Ability to speak/read English.
Exclusion
- No documented psychosis, blindness, dementia, active dialysis, substance abuse, amputations, or severe functional deficits, or recent major surgery or hospitalization in the past year.
Key Trial Info
Start Date :
September 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2023
Estimated Enrollment :
296 Patients enrolled
Trial Details
Trial ID
NCT04016558
Start Date
September 15 2019
End Date
February 15 2023
Last Update
October 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143